The global prevalence of MS is estimated at 36 people per
100,000 people, which means there are 2.8 million people
living with MS worldwide.
This equates to 1 in every 3,000 people living with the disease.
This global estimate has increased from 2.3 million
people in 2013, which is consistent with stated increases
in national prevalence in some countries
over this time.
A juicy market that will not disappear any time soon!
In a strange and sick way, the more MSers there are the more money is spent in this space amd the more likely we are to see innovation (to the benefit of the rest of us):
https://newatlas.com/medical/synthetic-molecules-repair-brain-disease-injury/
A shrinking market would have curtailed spending.
You are not alone in having that thought, but as you say, you feel a little guilty for it.
A very interesting map. Thank you for posting! Is there any way that it can be seen larger? It looks like The Netherlands, where I live, now has a higher number of people with MS than the UK. I can’t zoom in to check, however.
Hi Siobhan, Visit http://www.atlasofms.org and you can click on each country
Thanks so much for this. Is there any way I could get in touch with Clare Walton from MSIF – as I wanted to see if there was any ethnic/race breakdown MSIF might have?
Best, Rachel (Horne)
clare@msif.org
on web
Multiple sclerosis incidence and
prevalence in Ukraine over the last two
decades
Background and aims: Multiple sclerosis (MS)
epidemiological trends are a matter of a special attention
due to a growing significance of this disease, so the aim was
to reveal such trends in Ukraine.
Methods: Data of the official general and public health
statistics on regions of Ukraine since 2000 were examined
and used for the calculations.
Results: In 2000, the MS prevalence in Ukraine was 35.63
cases per 100,000 (middle-risk area) (Figure 1), but 5
regions were in a MS high-risk area (50-100 cases per
100,000) (Figure 2A). Ten years later, MS prevalence in
Ukraine has grown to 42.29 per 100,000 and 19 (70.1%)
regions of 27 ones were in the MS high-risk area (Figure
2B). In 2017, overall MS prevalence in Ukraine approached
to a high-risk threshold (49.16 per 100,000). During the last
two decades in Ukraine, with an average MS incidence of
2.60±0.18 cases per 100,000, there is an upward trend in
MS prevalence for Western and Central regions (Figure
2C). Medical check-up had risen from 83.9% to 92.0% in
this period.
Conclusion: An increasing of MS prevalence and incidence
in 2000-2010 was partly due to improvement of diagnostic
tools and physicians’ vigilance concerning MS diagnosis. A
slower-than-expected according to MS incidence growth of
MS prevalence in Ukraine resulted from migration
processes first of all. It should be taking into account also
that the statistical data since 2014 were under influence of
a number of factors not related to MS, particularly
sociopolitical ones.